Hypertrophy and increased glial fibrillary acidic protein are coupled to increased protection against cytotoxicity in glioma cell lines

Toxicology in Vitro : an International Journal Published in Association with BIBRA
Carole Mead, Vic W Pentreath

Abstract

This study examined the associations of increased glial fibrillary acidic protein (GFAP) levels and hypertrophie changes with susceptibility to toxic insult in C6 rat glioma cells. The cells were treated with serial pulses of dibutyryl-cAMP (dBcAMP) (each 48 hr) which increased levels of GFAP approximately twofold and the surface to volume ratio by approximately 1.7 times after the third pulse. This treatment reduced cell number by 22% and increased total protein by 10%. The cells were then exposed to different toxic substances [tin chloride, lead tetraacetate, chloroquine, cadmium chloride, aluminium chloride, mercuric chloride, acrylamide, triethyltin bromide, ethylenediaminetetraacetatic acid (EDTA)] and toxicity to the cells measured by the neutral red (NR) assay. With the exceptions of aluminium chloride and EDTA, 50% effective concentration (EC(50)) values for the toxic substances were increased up to 10,000 times (for cadmium chloride). Very similar increases in protection against the substances following dBcAMP treatment were found with the 1321N1 human astrocytoma cell line. We conclude that two components of gliosis, hypertrophy and increased GFAP, are associated with increased protection against a range of known neur...Continue Reading

References

Sep 1, 1992·Neurochemical Research·W T NortonC F Brosnan
Jan 1, 1991·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·A Bruinink, P Reiser
Jan 1, 1986·Brain Research·D L Davies, A Vernadakis
Dec 14, 1984·Science·B A MacVicar
Apr 1, 1994·Trends in Neurosciences·M K McMillianK R Pennypacker
Feb 1, 1995·Neurochemistry International·J P O'CallaghanD B Miller
Jul 1, 1994·Brain Pathology·L F Eng, R S Ghirnikar
May 1, 1993·Journal of Neuropathology and Experimental Neurology·F WandosellM Nieto-Sampedro
Jun 7, 2005·Expert Opinion on Drug Safety·James P O'Callaghan, Krishnan Sriram
Jun 1, 1996·Toxicology in Vitro : an International Journal Published in Association with BIBRA·M R Cookson, V W Pentreath
Jun 1, 1994·Toxicology in Vitro : an International Journal Published in Association with BIBRA·M R Cookson, V W Pentreath

❮ Previous
Next ❯

Citations

Sep 1, 2000·Chemico-biological Interactions·N D Slamon, V W Pentreath
Jul 6, 2014·BioMed Research International·Praveen KumarGurcharan Kaur
Jun 24, 2008·Critical Reviews in Toxicology·Edward J Calabrese
Jan 24, 2007·Toxicon : Official Journal of the International Society on Toxinology·A M M SilvaS L Costa
Jan 1, 2005·Nonlinearity in Biology, Toxicology, Medicine·N Debbie SlamonVic W Pentreath
Jan 1, 2004·Nonlinearity in Biology, Toxicology, Medicine·V W Pentreath, C Mead
Apr 25, 2008·Critical Reviews in Toxicology·Edward J Calabrese
Feb 24, 2001·Human & Experimental Toxicology·V W Pentreath, N D Slamon
Jan 18, 2018·Neurotoxicity Research·Victor Diogenes Amaral da SilvaSilvia Lima Costa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.